EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures

Antonia Gillmeister iD, Julia Husman, Renate Schmelz, Stefan Brückner, Jochen Hampe iD, Daniela Aust, Sebastian Zeissig

Liver International · 2026

DOI: 10.1111/liv.70865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Antonia Gillmeister und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden (TUD), Dresden, Germany. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Bile Duct Neoplasms, Cholangiocarcinoma, Cholestasis. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The differentiation between benign and malignant biliary strictures remains a significant clinical challenge. Recent studies have suggested that next generation sequencing (NGS) can improve the diagnostic accuracy. However, evidence on its performance in routine clinical practice is limited. Therefore, validation of the diagnostic value of NGS using real‐world clinical data is warranted. We compared the performance of NGS analysis of cholangiocellular carcinoma (CCC)‐associated mutations in endoscopic biopsies with that of histopathology, CA19‐9 and cross‐sectional imaging. NGS showed higher sensitivity for malignancy (65%) compared to histopathology (52%) at similar specificity (96% vs. 100%). The combination of NGS and histopathology further increased sensitivity for malignancy to 78% ( p = 0.03) at similar specificity (96%). Our data provide support for the use of NGS in the diagnostic workup of biliary strictures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingBile Duct NeoplasmsCholangiocarcinomaCholestasisHumansDiagnosis, DifferentialMutationSensitivity and SpecificityCholangiopancreatography, Endoscopic RetrogradeConstriction, PathologicCA-19-9 AntigenBile Ducts, IntrahepaticBiopsyFemale

Stichwörter der Autor:innen

BiliSeqERCPbiliary specimensbiliary stricturesnext generation sequencing (NGS)

Substanzen

CA-19-9 Antigen

Autor:innen und Institutionen

  • Department of Medicine I, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden (TUD), Dresden, Germany.
  • Institute for Pathology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden (TUD), Dresden, Germany.
  • Department of Visceral Surgery and Medicine, Inselspital - Bern University Hospital, University of Bern, Bern, Switzerland.

ORCID-Profile: Antonia Gillmeister, Jochen Hampe

Zitieren

APA

Gillmeister, A., Husman, J., Schmelz, R., Brückner, S., Hampe, J., Aust, D., & Zeissig, S. (2026). Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures. Liver International. https://doi.org/10.1111/liv.70865

Vancouver

Gillmeister A, Husman J, Schmelz R, Brückner S, Hampe J, Aust D, et al. Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures. Liver International. 2026. doi:10.1111/liv.70865

BibTeX
@article{Gillmeister2026,
  author = {Gillmeister, Antonia and Husman, Julia and Schmelz, Renate and Brückner, Stefan and Hampe, Jochen and Aust, Daniela and Zeissig, Sebastian},
  title = {Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70865}
}
Kostenlos starten →